0000-0002-4173-6634
Research Areas
Biotechnology, Genetics, Immunology, Molecular Genetics
Short CV
Cihan Taştan graduated from METU Molecular Biology and Genetics department in 2011 as a "High Honor" student. In the same year, he was awarded a full scholarship to pursue a PhD in Microbiology-Immunobiology at New York University. He completed his Ph.D. thesis in September 2017, especially on the relationships between human immune system cells and bacterial species in our body. He received his (PhD) title. In January 2015, he continued his research with the title of Pre-Doctoral Associate at The Jackson Laboratory-Genomic Medicine Institute. And he took part in the project to develop CRISPR genome modification techniques in human immune system cells. Based on these studies, from October 2017 to October 2020, he worked as the R&D Unit Manager at Acıbadem LabCell Cell Laboratory to produce genetically modified CAR-T cell therapies against cancer types and genetic treatments against genetic diseases (for example, Duchenne Muscular Dystrophy). He has continued his studies. He has extensive knowledge and experience in synthetic biology, genetic engineering and molecular biology covering undergraduate and doctoral periods. He is currently the founding director of the international rare diseases genetic therapy competition (radichal.com) and the hiDNA initiative (hi-dna.com), which develops platforms using DNA-based cryptology, DNA barcoding, healthcare, and blockchain technology. He is the director of CRISPR Valley (crisprvalley.com), where CRISPR gene engineering technologies are produced and trained. He continues to work as a faculty member at Üsküdar University, Department of Molecular Biology and Genetics, and as the director of the Transgenic Cell Technologies Application and Research Center (TRGENMER).